Lung Cancer Modern Multidisciplinary Management
Lung cancer continues to be the leading cause of cancer mortality worldwide among both men and women. Recent advances in prevention, screening and management in the past decade have led to significant improvements in survival and quality of life. Local treatments like minimally invasive surgery, rad...
Saved in:
Other Authors: | |
---|---|
Format: | Electronic Book Chapter |
Language: | English |
Published: |
IntechOpen
2021
|
Subjects: | |
Online Access: | DOAB: download the publication DOAB: description of the publication |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000naaaa2200000uu 4500 | ||
---|---|---|---|
001 | doab_20_500_12854_131130 | ||
005 | 20231201 | ||
003 | oapen | ||
006 | m o d | ||
007 | cr|mn|---annan | ||
008 | 20231201s2021 xx |||||o ||| 0|eng d | ||
020 | |a intechopen.92053 | ||
020 | |a 9781789855760 | ||
020 | |a 9781789855753 | ||
020 | |a 9781789856385 | ||
040 | |a oapen |c oapen | ||
024 | 7 | |a 10.5772/intechopen.92053 |c doi | |
041 | 0 | |a eng | |
042 | |a dc | ||
072 | 7 | |a MJCL |2 bicssc | |
100 | 1 | |a Park, Henry S. |4 edt | |
700 | 1 | |a Park, Henry S. |4 oth | |
245 | 1 | 0 | |a Lung Cancer |b Modern Multidisciplinary Management |
260 | |b IntechOpen |c 2021 | ||
300 | |a 1 electronic resource (224 p.) | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
520 | |a Lung cancer continues to be the leading cause of cancer mortality worldwide among both men and women. Recent advances in prevention, screening and management in the past decade have led to significant improvements in survival and quality of life. Local treatments like minimally invasive surgery, radiotherapy, and image-guided ablation have contributed to improving the effectiveness and tolerability of potentially curative treatments in early-stage, locally advanced, and oligometastatic/oligoprogressive disease. Chemotherapy, targeted therapy, immunotherapy, and palliative local therapy options have expanded rapidly, with new regimens showing improved outcomes even for those with widely metastatic disease. This book comprehensively reviews the evidence that has driven personalized medicine, based on a variety of multidisciplinary perspectives by international lung cancer experts. | ||
540 | |a Creative Commons |f https://creativecommons.org/licenses/by/3.0/ |2 cc |4 https://creativecommons.org/licenses/by/3.0/ | ||
546 | |a English | ||
650 | 7 | |a Oncology |2 bicssc | |
653 | |a minimally invasive surgery, robotic surgery, immunotherapy, radiotherapy, mirna, liquid biopsy | ||
856 | 4 | 0 | |a www.oapen.org |u https://mts.intechopen.com/storage/books/10437/authors_book/authors_book.pdf |7 0 |z DOAB: download the publication |
856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/131130 |7 0 |z DOAB: description of the publication |